Hua Medicine (02552) released its monthly return for the period ending 30 November 2025. Total authorized share capital remained at 2,000,000,000 ordinary shares, each with a par value of USD 0.001, amounting to USD 2,000,000 in aggregate.

The total number of issued shares stood at 1,056,605,016, with no change during the reporting period. Under the post-IPO share option scheme, 20,000,000 new share options were granted in November, raising the total outstanding share options from 59,289,669 to 79,289,669. No options were exercised, canceled, or lapsed during the month, and there was no change in treasury shares.